Terry-Ann Burrell - 18 Jan 2023 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)

Role
Chief Financial Officer
Signature
By: /s/ Christine Bellon, Attorney-in-fact
Issuer symbol
BEAM
Transactions as of
18 Jan 2023
Net transactions value
-$1,584,742
Form type
4
Filing time
20 Jan 2023, 15:18:22 UTC
Previous filing
05 Jan 2023
Next filing
25 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BEAM Common Stock Options Exercise $545,640 +39,886 +103% $13.68 78,472 18 Jan 2023 Direct F1, F2
transaction BEAM Common Stock Sale $2,130,382 -47,195 -60% $45.14 31,277 18 Jan 2023 Direct F2, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BEAM Stock Option (Right to Buy) Options Exercise $0 -39,886 -14% $0.000000 243,055 18 Jan 2023 Common Stock 39,886 $13.68 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
F2 Includes 308 shares acquired by the Reporting Person under the Beam Therapeutics Inc. ("BEAM") Amended and Restated 2019 Employee Stock Purchase Plan on September 30, 2022.
F3 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F4 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.50, inclusive. The Reporting Person undertakes to provide BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F5 The option vested as to 25% on the first anniversary of the of the vesting commencement date, August 20, 2019, and continues to vest at a rate of 2.78% each month thereafter until the option is fully vested.